Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced Cardiomyopathy

NCT06304896 is registered in ClinicalTrials.gov with Arab Contractors Medical Centre as lead sponsor.

NCT NCT06304896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06304896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced Cardiomyopathy
Lead sponsor
Arab Contractors Medical Centre
Phase
Phase 1
Overall status
Unknown status
Start date
May 1, 2024
Completion date
December 1, 2025
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy induced systolic dysfunction